NCT00704717View on ClinicalTrials.gov

Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301)

CompletedOBSERVATIONAL

Enrollment

185

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Hepatitis C, ChronicHepatitis C

Interventions

BIOLOGICAL

PegIntron (peginterferon alfa-2b; SCH 54031) pen

PegIntron pen administered in accordance with approved labeling

DRUG

Rebetol (ribavirin; SCH 18908)

Rebetol administered in accordance with approved labeling.

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00704717 - Evaluation of Patient Satisfaction in Hepatitis C Patients Treated With PegIntron Pen and Rebetol in Romania (Study P04301) | Biotech Hunter | Biotech Hunter